Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for airway infection prevention in children with structural lung damage
NCT06409299Phase 3Not yet recruiting
- Sponsor
- Rigshospitalet
- Start
- Sep 2024
- Primary completion
- Mar 2027
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of azithromycin in respiratory tract infection (RTI), sponsored by Rigshospitalet. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
azithromycin
03
Conditions
respiratory tract infection (RTI)
Beyond the preview
Go deeper on NCT06409299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06409299.